NeoGenomics Announces Preliminary Quarter 3 Results,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
114
NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance

FORT MYERS, FL --(Marketwired - October 12, 2017) - NeoGenomics, Inc. ( NASDAQ : NEO ) , a leading provider of cancer-focused genetic testing services, announced today that it expects to report Quarter 3 revenue of approximately $63.1 million and Adjusted EBITDA (1) of approximately $6.0 million.

Clinical genetic test volume is expected to be approximately 162,500 tests, an increase of over 16% versus last year, and average-revenue-per-clinical-genetic test ("Revenue per Test") is expected to be approximately $343, an 11% decrease from last year. Average-cost-of-goods-sold per test ("Cost per Test") is expected to be approximately $181, an 11% improvement from last year, and consolidated gross profit margin is expected to be 45.7%, an increase of 70 basis points versus last year.

NeoGenomics estimates that Hurricanes Harvey and Irma depressed revenue by approximately $1.0 million in Quarter 3. The Company also expects to record a one-time, $1.3 million revenue adjustment to reflect a change in the process for estimating revenue for unbilled tests at quarter end. In addition, as a result of the divestiture of PathLogic, third quarter revenue will be approximately $1.3 million less than in Quarter 2.

The Company believes the impact to Adjusted EBITDA from hurricanes was approximately $1.2 million as a result of the lost revenue and overtime charges incurred to process re-routed specimens in laboratory facilities not affected by the storms. Adjusted EBITDA will also be impacted by the one-time, $1.3 million change in unbilled revenue estimate and by higher bad debt expense, partially offset by an increase resulting from the divestiture of PathLogic.

Douglas VanOort, the Company Chairman and CEO, commented, "The Company's growth momentum and cost containment programs are strong. Despite the impact of two hurricanes, our Clinical Services Division test volume grew by over 16%, and our Pharma Services Division grew revenue by 38% to a record $6.9 million. Although Adjusted EBITDA will be lower than we expected in Quarter 3, we are driving significant reductions in Cost per Test, and are confident we can improve profit margins in future quarters."

Preliminary Fourth Quarter 2017 Financial Outlook:

The Company also announced preliminary guidance for the fourth quarter 2017 today that takes into consideration the divestiture of PathLogic. Based on current trends in operations, the Company expects consolidated revenue of $65 - $67 million and Adjusted EBITDA (1) of $9-10 million in the fourth quarter. The Company reserves the right to adjust this guidance at any time based on the ongoing execution of its business plan. Current and prospective investors are encouraged to perform their own due diligence before buying or selling any of the Company's securities, and are reminded that the foregoing estimates should not be construed as a guarantee of future performance.

(l)  "Adjusted EBITDA" is a non-GAAP financial measure and is defined by NeoGenomics as net income from continuing operations before: (i) interest expense, (ii) tax expense, (iii) depreciation and amortization expense, (iv) non-cash, stock-based compensation expense, and if applicable in a reporting period (v) acquisition related transaction expenses (vi) non-cash impairments of intangible assets (vii) debt financing costs (viii) and other significant non-recurring or non-operating (income) or expenses. The basis for making these adjustments to GAAP income from continuing operations is explained in the Company's Quarter 2, 2017 Earnings Release, dated July 25, 2017 in section entitled, Basis for Non-GAAP Adjustments. The Company will include a table reconciling Quarter 3 Adjusted EBITDA and Quarter 4 preliminary guidance to income from Continuing Operations as part of its Quarter 3 Earnings Release, which is scheduled for October 25, 2017

About NeoGenomics, Inc.

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for Physicians to help them diagnose and treat cancer. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CLIA certified laboratories in Aliso Viejo and Fresno, California; Tampa and Fort Myers, Florida; Houston, Texas and Nashville, Tennessee. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, integrated service delivery networks, and managed care organizations throughout the United States. For additional information about NeoGenomics, visit www.neogenomics.com .

Forward Looking Statements

Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward-looking statements, Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to continue gaining new customers, offer new types of tests, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC.

For further information, please contact: NeoGenomics, Inc. Steven C. Jones Director of Investor Relations (239) 325-2001 sjones@neogenomics.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 41

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 97

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 100

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 94

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 137

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 111

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 111

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 104

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Mission Rock Takes Charge of Seasons at Horsetooth

Updated Category News Views 20

Mission Rock Shakes Up Colorado's Apartment Market Here's one for the books: Mission Rock Residential, known for its no-nonsense approach to property management, just snagged a juicy piece of the market by taking over management at Seasons at Horsetooth Crossing in Fort Collins. Fort Collins isn't just some random name on the map—it's a hotbed for real estate, thanks to...

Continue Reading
Teck Resources Confirms Quarterly Dividend for Shareholders

Updated Category News Views 175

Teck Resources Declares New Dividend for Shareholders Teck Resources Limited (NYSE: TECK) has made an exciting announcement that will please its investors. The company has declared a quarterly dividend of $0.125 per share designated for its outstanding Class A common shares and Class B subordinate voting shares. This dividend is set to be paid on March 31 to all...

Continue Reading
Empowering Voices: The Impact of the AWDPI Conference

Updated Category News Views 300

Empowering Women Through Innovative Discussions The recent conference organized by the Asian Women Development Plan International brought together over 10,000 individuals passionate about empowering Asian women. This pivotal gathering, titled "The Conference of Asian Women Development International 2024", served as a beacon for women's issues, fostering a collaborative...

Continue Reading
O2Gold Shares Significant Updates on Quebec Aur Acquisition

Updated Category News Views 205

O2Gold's Exciting Update on Quebec Aur Acquisition O2Gold Inc. (NEX:OTGO.H), a dynamic player in the mineral exploration landscape, is thrilled to provide an update on its ongoing journey towards acquiring a gold mining exploration property in Quebec. This acquisition is through the purchase of Quebec Aur Ltd., with the transaction details specified in a share exchange...

Continue Reading
Skycorp Solar Group Limited Announces Major IPO Initiative

Updated Category News Views 187

Skycorp Solar Group Limited Announces Major IPO Initiative Skycorp Solar Group Limited (PN) has made a notable move by filing for an initial public offering (IPO) that encompasses 2,000,000 shares. The pricing is positioned attractively between $4 and $5 per share, appealing to a diverse range of potential investors. Understanding the IPO Process An IPO is a crucial step...

Continue Reading